ULK4 and cancer: Predicted HFI SNVs were not distributed evenly across disease subsets; SNVs in ULK4, BMP2K, PALB2, ALPK3 were more frequent in triple negative cancers (TNBC) whereas SNVs in EPHA2 was more common in ER positive cancers.